Search results for "Vaccines"
Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find
A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
https://immattersacp.org/weekly/archives/2022/06/21/2.htm
21 Jun 2022
FDA considers new approach to safe disposal of opioids
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/06/fda-considers-new-approach-to-safe-disposal-of-opioids.htm
1 Jun 2022
Advocacy is a marathon that mimics our patient encounters
We do advocacy work on a daily basis when we see patients, and we have to approach our interactions with legislators in a similar way.
https://immattersacp.org/archives/2022/06/advocacy-is-a-marathon-that-mimics-our-patient-encounters.htm
1 Jun 2022
MKSAP Quiz: Evaluation for influenza immunization
A 49-year-old man is evaluated for influenza immunization. Two weeks ago, he underwent surgical resection for stage III colon cancer. He will begin a 3-month course of adjuvant chemotherapy in 3 weeks. What is the preferred influenza immunization strategy?
https://immattersacp.org/weekly/archives/2022/05/24/3.htm
24 May 2022
Studies examine persistent symptoms of COVID-19
A U.K. study found that COVID-19 vaccination after infection may help persistent symptoms, while a U.S. study found that the burden of such symptoms appears high.
https://immattersacp.org/weekly/archives/2022/05/24/5.htm
24 May 2022
New COVID-19 vaccines tested, authorization changes in progress for existing vaccines
The FDA further limited use of the Johnson & Johnson (Janssen) vaccine and scheduled advisory committee meetings on other vaccine questions. Two non-mRNA vaccines showed effectiveness, and other studies looked at antibody prevalence, home test accuracy, and long-term symptoms.
https://immattersacp.org/weekly/archives/2022/05/10/2.htm
10 May 2022
Details on second mRNA COVID-19 vaccine boosters
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/05/details-on-second-mrna-covid-19-vaccine-boosters.htm
1 May 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/05/latest-updates-on-acps-priorities-initiatives.htm
1 May 2022
Perioperative medicine changed in the pandemic
In the face of a lack of guidance on perioperative medicine during the COVID-19 pandemic, many hospitals are developing their own guidelines on timing of surgery after infection in vaccinated patients.
https://immattersacp.org/archives/2022/05/perioperative-medicine-changed-in-the-pandemic.htm
1 May 2022
Fourth vaccine dose 62% effective against severe COVID-19 in month after receipt
Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
https://immattersacp.org/weekly/archives/2022/04/19/4.htm
19 Apr 2022